You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API MACIMORELIN ACETATE

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing MACIMORELIN ACETATE

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novo Nordisk	MACRILEN	macimorelin acetate	0169-1401	CROSPOVIDONE	2024-12-20
Novo Nordisk	MACRILEN	macimorelin acetate	0169-1401	LACTOSE MONOHYDRATE	2024-12-20
Novo Nordisk	MACRILEN	macimorelin acetate	0169-1401	SACCHARIN SODIUM	2024-12-20
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for MACIMORELIN ACETATE

Excipient focus: CROSPOVIDONE

MACIMORELIN ACETATE drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novo Nordisk	macimorelin acetate	0169-1401
Strongbridge US Inc	macimorelin acetate	71090-002
>Company	>Ingredient	>NDC

MACIMORELIN ACETATE drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

MACIMORELIN ACETATE drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novo Nordisk	macimorelin acetate	0169-1401
Strongbridge US Inc	macimorelin acetate	71090-002
>Company	>Ingredient	>NDC

MACIMORELIN ACETATE drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SACCHARIN SODIUM

MACIMORELIN ACETATE drug variants containing SACCHARIN SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novo Nordisk	macimorelin acetate	0169-1401
Strongbridge US Inc	macimorelin acetate	71090-002
>Company	>Ingredient	>NDC

MACIMORELIN ACETATE drug variants not containing SACCHARIN SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

MACIMORELIN ACETATE drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novo Nordisk	macimorelin acetate	0169-1401
Strongbridge US Inc	macimorelin acetate	71090-002
>Company	>Ingredient	>NDC

MACIMORELIN ACETATE drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STEARYL FUMARATE

MACIMORELIN ACETATE drug variants containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novo Nordisk	macimorelin acetate	0169-1401
Strongbridge US Inc	macimorelin acetate	71090-002
>Company	>Ingredient	>NDC

MACIMORELIN ACETATE drug variants not containing SODIUM STEARYL FUMARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.